Masatsugu Miyara Selected Research

1- (3',4'- dihydroxybenzyl)- 1,2,3,4- tetrahydroisoquinoline

9/2014

Endogenous neurotoxic dopamine derivative covalently binds to Parkinson's disease-associated ubiquitin C-terminal hydrolase L1 and alters its structure and function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masatsugu Miyara Research Topics

Disease

1	Neuroblastoma 01/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2022
1	Starvation 01/2017
1	Parkinson Disease (Parkinson's Disease) 09/2014
1	Parkinsonian Disorders (Parkinsonism) 09/2014

Drug/Important Bio-Agent (IBA)

2	Messenger RNA (mRNA)IBA 01/2023 - 09/2022
1	Kelch-Like ECH-Associated Protein 1IBA 01/2023
1	TrehaloseIBA 09/2022
1	DisaccharidesIBA 09/2022
1	Proteins (Proteins, Gene)FDA Link 09/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 09/2014
1	1- (3',4'- dihydroxybenzyl)- 1,2,3,4- tetrahydroisoquinolineIBA 09/2014
1	Dopamine (Intropin)FDA LinkGeneric 09/2014
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 09/2014
1	catechol (pyrocatechol)IBA 09/2014